Exfoliative dermatitis - Exfoliative Dèrmatoz
☆ AI Dermatology — Free Service
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
Syndwòm Po Wouj (k ap boule) ― Eritèm ak echèl sou tout kò a se sentòm prensipal Exfoliative Dèrmatoz (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma se yon maladi po ki ra men grav. Pandan ke kòz egzak la souvan enkoni, li ka deklanche pa yon reyaksyon dwòg oswa yon kansè kache. Youn nan kansè ki souvan asosye ak dèrmatit èksfolyativ se lenfom T‑selil kutane, ki ka pa montre sentòm pou mwa oswa menm ane apre kondisyon po a parèt. Anjeneral, ospitalizasyon nesesè pou premye evalyasyon ak tretman. Pasyan ki gen maladi ki soti nan dwòg anjeneral gen yon bon pwospèktif alontèm, menm si ka ki pa gen yon kòz klè souvan gen tandans pou repete epi remisyon. Pwostik la pou ka ki lye ak kansè anjeneral depann sou fason kansè a pwogrese.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Li souvan montre woujè ki gaye toupatou, kouvri plis pase 90 % kò a. Kondisyon sa a se yon siy vizib ki ka endike plizyè pwoblèm sante kache, tankou psoriasis, ekzema, oswa yon repons a sèten medikaman.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Kòz ki pi komen pou erythroderma se agrave yon maladi po ki deja egziste, tankou psoriasis, dèrmatoz kontak, dèrmatoz seboreik, lichen planus, pityriasis rubra pilaris, oswa yon reyaksyon dwòg, tankou itilizasyon steroid. Manifès prensipal la se ra, epi anjeneral li parèt nan ka lenfòm T‑selil kutane. Paske li enpòtan pou diferansye li ak lenfòm T‑selil kutane, yo fè yon biyopsi.